SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027371
Filing Date
2022-11-14
Accepted
2022-11-14 17:22:40
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20220930_10q.htm   iXBRL 10-Q 989367
2 EXHIBIT 31.1 ex_438806.htm EX-31.1 13734
3 EXHIBIT 31.2 ex_438807.htm EX-31.2 13753
4 EXHIBIT 32.1 ex_438808.htm EX-32.1 8652
  Complete submission text file 0001437749-22-027371.txt   5266619

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA stab-20220930.xsd EX-101.SCH 56760
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stab-20220930_cal.xml EX-101.CAL 51001
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220930_def.xml EX-101.DEF 393345
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220930_lab.xml EX-101.LAB 365013
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220930_pre.xml EX-101.PRE 423007
61 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220930_10q_htm.xml XML 603574
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 221387885
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences